Market revenue in 2020 | USD 66.2 million |
Market revenue in 2028 | USD 188.8 million |
Growth rate | 14% (CAGR from 2020 to 2028) |
Largest segment | Lymphoma |
Fastest growing segment | Lymphoma |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Leukemia, Lymphoma, MPNs, Other Cancers |
Key market players worldwide | Roche Holding AG, Abbott Laboratories, Qiagen NV, Danaher Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemato oncology testing market will help companies and investors design strategic landscapes.
Lymphoma was the largest segment with a revenue share of 45.77% in 2020. Horizon Databook has segmented the India hemato oncology testing market based on leukemia, lymphoma, mpns, other cancers covering the revenue growth of each sub-segment from 2018 to 2028.
India has the third-highest number of blood cancer patients after the U.S. and China. Blood cancer contributes around 7% of all cancer cases in India. According to Globocan estimates, in 2020 around 48,419 new cases of leukemia and 35,828 new cases of non-Hodgkin lymphoma were diagnosed in India.
High prevalence of blood cancer makes India a high-potential region for hemato oncology testing solutions. However, low awareness regarding blood cancer and its early diagnosis is expected to be a major threat to the market.
According to the Make Blood Cancer Visible survey conducted by Janssen Asia Pacific in 2018, around 80% of cancer in India is detected late and only 20% of cancers are diagnosed at stage 1 or 2. Further, launch of technological advanced products will create lucrative opportunities over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the India hemato oncology testing market , including forecasts for subscribers. This country databook contains high-level insights into India hemato oncology testing market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account